Target intelligence / Profile preview

Fructose phosphotransferase system (Fru-PTS)

Target
Fru-PTS
Molecular classification
Enzyme, Transporter, Phosphotransferase
01

Overview

The Fructose phosphotransferase system (Fru-PTS) is a complex bacterial transport system that facilitates the simultaneous translocation and phosphorylation of fructose across the cytoplasmic membrane. It functions as part of the larger phosphoenolpyruvate (PEP)-dependent sugar phosphotransferase system, utilizing PEP as a high-energy phosphate donor to convert fructose into fructose-1-phosphate during transport (UniProt, 2023). This system typically consists of general components like Enzyme I and HPr, alongside the fructose-specific Enzyme II (EII) complex, which provides the substrate specificity (PubMed, PMID: 15659676). Beyond its role in nutrient acquisition, the Fru-PTS is a critical regulator of bacterial physiology, influencing carbon catabolite repression and the expression of virulence factors in various pathogens (Microbiology Spectrum, 2015). Because the PTS is unique to bacteria and absent in humans, it is considered a promising target for the development of narrow-spectrum antimicrobial agents (PubMed, PMID: 22493367). Inhibiting this system can impair bacterial growth and reduce the fitness of pathogens like Streptococcus mutans in the oral cavity or enteric pathogens in the gut (Journal of Bacteriology, 2010). Current therapeutic strategies involve the use of PEP analogs or small molecules that disrupt the phosphorelay or the transport channel itself.

Other names
Fructose-specific phosphotransferase systemEnzyme II fructosePEP-dependent fructose phosphotransferase systemPTS fructose-specific EIIABC componentFru-PTS
02

Mechanism of action

Inhibition of the phosphoenolpyruvate-dependent transport and phosphorylation of fructose, disrupting bacterial energy metabolism and signal transduction.

03

Biological functions

Carbohydrate transportSugar phosphorylationCarbon catabolite repressionMetabolic regulation
04

Disease associations

Bacterial infectionDental cariesPathogenesis
05

Safety considerations

Disruption of the gut microbiomePotential for rapid development of bacterial resistanceLimited efficacy against non-PTS dependent pathogens
06

Interacting drugs

Fluoride

2 more in the full profile.

07

Biomarkers

Bacterial growth rateIntracellular fructose-1-phosphate levelsPEP/pyruvate ratio

Beyond the preview

Go deeper on Fructose phosphotransferase system (Fru-PTS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fructose phosphotransferase system (Fru-PTS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call